Temocillin for non-urinary tract infections caused by AmpC-producing Enterobacterales: Is it a feasible option?
Having led to favorable outcomes, temocillin may represent a carbapenem-sparing option when in vitro susceptibility is confirmed. These findings call for further evaluation in larger prospective clinical studies.
Authors
- Christel Mamona-Kilu
- Bui Hai Hoang
Institutions
- Hanoi Medical University (VN)
- Hôpital Raymond-Poincaré (FR)
- Hôpital Foch (FR)
Publication Details
- Journal
- Infectious Diseases Now
- Published
- 2026-02-14
- DOI
- https://doi.org/10.1016/j.idnow.2026.105257
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00